U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07165912) titled 'Effects of a Group Versus Individual Cognitive Training Program on Chemotherapy-induced Cognitive Impairment (Chemobrain) in Breast Cancer Patients Undergoing Active Treatment' on Sept. 02.

Brief Summary: Introduction: The significant improvement in breast cancer survival, largely attributable to biomedical and technological progress, makes it increasingly necessary to investigate the secondary effects linked to this pathology. Among these, cancer-related cognitive impairment (CRCI) stands out as one of the most frequent yet frequently overlooked complications.

Objective: To evaluate the impact of a structured cognitive training p...